i.ndiaye
Submits third-party assay reports on material purchased directly. Based in Essen.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.33%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041850 | TB-500 | JEEP | JEEP-2602-V3434 | Medutest | 2026-Q3 | 99.93 | 3.44 | 99.1 | Supplier-supplied | 2 | FAIL |
| AX-2026-043018 | Semaglutide | KP | KP-2511-J4998 | Janoshik | 2026-Q2 | 99.93 | 7.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042355 | TB-500 | HJ | HJ-2601-H3602 | PeptideMeter | 2026-Q1 | 99.93 | 6.10 | 107.3 | Supplier-supplied | 0 | PASS |
| AX-2025-019644 | Semaglutide | Homopeptide | HOMO-2508-K2535 | Kestrel | 2025-Q4 | 99.93 | 3.72 | 92.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018992 | N-Acetyl Semax Amide | FGP | FGP-2508-R1956 | PeptideMeter | 2025-Q3 | 99.25 | 8.46 | 103.8 | Supplier-supplied | 0 | PASS |
| AX-2025-018990 | KPV | FGP | FGP-2506-L1816 | VendorInvestigate | 2025-Q3 | 99.33 | 4.08 | 103.5 | Buyer-sourced | 0 | FAIL |
| AX-2024-005202 | PT-141 (Bremelanotide) | SSA | SSA-2403-F6387 | Janoshik | 2024-Q3 | 97.87 | 5.24 | 89.6 | Buyer-sourced | 1 | FAIL |
| AX-2024-005434 | Selank | WXT | WXT-2406-W5390 | Medutest | 2024-Q3 | 99.05 | 9.66 | 94.8 | Buyer-sourced | 0 | PASS |
| AX-2024-004981 | Semaglutide | GGPeps | GGPE-2408-Y9789 | Janoshik | 2024-Q3 | 97.84 | 5.70 | — | Supplier-supplied | 2 | MARGINAL |